- Home
- EIC vs XBIT Comparison
EIC vs XBIT Comparison
Compare EIC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | XBIT |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.3M | 71.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | EIC | XBIT |
|---|---|---|
| Price | $9.21 | $2.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.63 | N/A |
| AVG Volume (30 Days) | ★ 174.1K | 46.4K |
| Earning Date | 02-26-2026 | 03-13-2026 |
| Dividend Yield | ★ 14.03% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.37 | N/A |
| Revenue Next Year | $1.08 | N/A |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.17 | $2.09 |
| 52 Week High | $15.20 | $3.62 |
Technical Indicators
Market Signals| Indicator | EIC | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 33.63 | 43.82 |
| Support Level | N/A | $2.15 |
| Resistance Level | $10.15 | $2.69 |
| Average True Range (ATR) | 0.17 | 0.07 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 10.53 | 36.86 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.